Simon Gaisford
Overview
Explore the profile of Simon Gaisford including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
3457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sangfuang N, McCoubrey L, Awad A, Marzorati M, Ghyselinck J, Verstrepen L, et al.
Transl Res
. 2025 Feb;
278:36-47.
PMID: 39986536
Inflammatory Bowel Disease (IBD) is characterized by chronic inflammation in the gastrointestinal tract, and is usually accompanied by dysbiosis in the gut microbiome, a factor that contributes to disease progression....
2.
Ju T, Li J, Weston A, Satta G, Bolognini S, Di Luca M, et al.
Macromol Rapid Commun
. 2025 Jan;
e2400744.
PMID: 39803850
Antimicrobial resistance poses a growing threat to public health globally. Multidrug resistant Pseudomonas (P.) aeruginosa is detected in many infected wounds and is very challenging to treat with antibiotics. An...
3.
Li H, E Alkahtani M, Basit A, Elbadawi M, Gaisford S
Int J Pharm
. 2024 Nov;
:123561.
PMID: 39492436
3D Printing (3DP) of pharmaceuticals could drastically transform the manufacturing of medicines and facilitate the widespread availability of personalised healthcare. However, with increasing awareness of the environmental damage of manufacturing,...
4.
Fredua-Agyeman M, Stapleton P, Gaisford S
Anaerobe
. 2024 Nov;
:102790.
PMID: 39492420
Objectives: In this work, an isothermal microcalorimeter was applied to investigate the antipathogenic activity of three probiotics (Lactobacillus acidophilus, Bifidobacterium lactis and Bifidobacterium bifidum) against Pseudomonas aeruginosa, Staphylococcus aureus and...
5.
Ong J, Jorgensen A, Zhu Z, Telford R, Davies P, Gaisford S, et al.
Drug Deliv Transl Res
. 2024 Oct;
PMID: 39424706
Vat photopolymerisation 3D printing is being actively explored for manufacturing personalised medicines due to its high dimensional accuracy and lack of heat application. However, several challenges have hindered its clinical...
6.
Elbadawi M, Li H, Ghosh P, E Alkahtani M, Lu B, Basit A, et al.
ACS Sustain Chem Eng
. 2024 Aug;
12(30):11155-11166.
PMID: 39091925
Selective laser sintering (SLS) is an emerging three-dimensional (3D) printing technology that uses a laser to fuse powder particles together, which allows the fabrication of personalized solid dosage forms. It...
7.
Favaron A, Abdalla Y, McCoubrey L, Nandiraju L, Shorthouse D, Gaisford S, et al.
Eur J Pharm Sci
. 2024 Jul;
200:106845.
PMID: 38971433
The gut microbiota is a complex ecosystem, home to hundreds of bacterial species and a vast repository of enzymes capable of metabolising a wide range of pharmaceuticals. Several drugs have...
8.
McCoubrey L, Ferraro F, Seegobin N, Verin J, Alfassam H, Awad A, et al.
J Control Release
. 2024 Mar;
369:163-178.
PMID: 38521168
The production of short chain fatty acids (SCFAs) by the colonic microbiome has numerous benefits for human health, including maintenance of epithelial barrier function, suppression of colitis, and protection against...
9.
Austin P, Green S, Gaisford S
Nutrition
. 2024 Feb;
121:112353.
PMID: 38402669
Objective: The same microbial species isolated from blood simultaneously drawn from a central venous catheter hub and a peripheral vein (paired blood cultures) during parenteral nutrition may be assumed to...
10.
Favaron A, Turkgeldi E, Elbadawi M, Gaisford S, Basit A, Orlu M
Reprod Biomed Online
. 2024 Feb;
48(4):103734.
PMID: 38359733
Disruption of women's gut and cervicovaginal microbiota has been associated with multiple gynaecological diseases such as endometriosis, polycystic ovary syndrome, non-cyclic pelvic pain and infertility. Female infertility affects 12.6% of...